Welcome to Drug and Therapeutics Bulletin (DTB). For 50 years, Drug and Therapeutics Bulletin (DTB) has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals. DTB has always been wholly independent of the pharmaceutical industry, Government and regulatory authorities. DTB is also free of advertising and other forms of commercial sponsorship.
Latest Articles
- Delayed drug hypersensitivity reaction to secukinumab in a patient with hidradenitis suppurativa
- Recent updates from the BNF (BNF 87)
- Donanemab in early symptomatic Alzheimer’s disease
- Medicines and global warming: a complex problem
- Cytisine for smoking cessation
POPULAR ARTICLES
- Review
- BNF update
- Review
- DTB select
- Editorial
Related Journals
